Most read article(s)

You have access
Molecular, Behavioral, and Physiological Consequences of Methamphetamine Neurotoxicity: Implications for Treatment
Anna Moszczynska and Sean Patrick Callan

Journal of Pharmacology and Experimental Therapeutics September 2017, 362 (3) 474-488; DOI: https://doi.org/10.1124/jpet.116.238501
You have access
Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for the Topical Treatment of Atopic Dermatitis
Hidetaka Hiyama, Naoya Arichika, Minoru Okada, Noriyuki Koyama, Tomonori Tahara and Junpei Haruta

Journal of Pharmacology and Experimental Therapeutics April 11, 2023, JPET-AR-2023-001609; DOI: https://doi.org/10.1124/jpet.123.001609
You have access
Discovery and Preclinical Characterization of GSK1278863 (Daprodustat), a Small Molecule Hypoxia Inducible Factor–Prolyl Hydroxylase Inhibitor for Anemia
Jennifer L. Ariazi, Kevin J. Duffy, David F. Adams, Duke M. Fitch, Lusong Luo, Melissa Pappalardi, Mangatt Biju, Erin Hugger DiFilippo, Tony Shaw, Ken Wiggall and Connie Erickson-Miller

Journal of Pharmacology and Experimental Therapeutics December 2017, 363 (3) 336-347; DOI: https://doi.org/10.1124/jpet.117.242503
You have access
Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans
Vivaswath S. Ayyar, Dawei Song, Songmao Zheng, Thomas Carpenter and Donald L. Heald

Journal of Pharmacology and Experimental Therapeutics November 2021, 379 (2) 134-146; DOI: https://doi.org/10.1124/jpet.121.000805
Open Access
Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein
Julie S. Moyers, Ryan J. Hansen, Jonathan W. Day, Craig D. Dickinson, Chen Zhang, Xiaoping Ruan, Liyun Ding, Robin M. Brown, Hana E. Baker and John M. Beals

Journal of Pharmacology and Experimental Therapeutics September 2022, 382 (3) 346-355; DOI: https://doi.org/10.1124/jpet.122.001105
You have access
A Retinoic Acid Receptor β₂ Agonist Improves Cardiac Function in a Heart Failure Model
Xiao-Han Tang, Jessica Gambardella, Stanislovas Jankauskas, Xujun Wang, Gaetano Santulli, Lorraine J. Gudas and Roberto Levi

Journal of Pharmacology and Experimental Therapeutics November 2021, 379 (2) 182-190; DOI: https://doi.org/10.1124/jpet.121.000806
You have access
The Role of Histamine H₁, H₂ and H₃ Receptors on Enteric Ascending Synaptic Transmission in the Guinea Pig Ileum
Angelo A. Izzo, Marcello Costa, Nicola Mascolo and Francesco Capasso

Journal of Pharmacology and Experimental Therapeutics December 1998, 287 (3) 952-957;
Open Access
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D₂ Receptor Mechanism of Action
Nina Dedic, Philip G. Jones, Seth C. Hopkins, Robert Lew, Liming Shao, John E. Campbell, Kerry L. Spear, Thomas H. Large, Una C. Campbell, Taleen Hanania, Emer Leahy and Kenneth S. Koblan

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 1-14; DOI: https://doi.org/10.1124/jpet.119.260281
You have access
Identification and Characterization of Two Structurally Related Dipeptides that Enhance Catalytic Efficiency of Neurolysin
Srinidhi Jayaraman, Joanna Kocot, Shiva Hadi Esfahani, Naomi J. Wangler, Arzu Uyar, Yehia Mechref, Paul C. Trippier, Thomas J. Abbruscato, Alex Dickson, Hideki Aihara, David A. Ostrov and Vardan T. Karamyan

Journal of Pharmacology and Experimental Therapeutics November 2021, 379 (2) 191-202; DOI: https://doi.org/10.1124/jpet.121.000840
Open Access
Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling
Zizhen Si and Xidi Wang

Journal of Pharmacology and Experimental Therapeutics May 2021, 377 (2) 207-217; DOI: https://doi.org/10.1124/jpet.120.000324

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals